The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Toxicity assessment of nanoparticles in various systems and organs
Open accessAbstract
In the past decades, much attention has been paid to toxicity assessment of nanoparticles prior to clinical and biological applications. While in vitro studies have been increasing constantly,in vivo studies of nanoparticles have not established a unified system until now. Predictive models and validated standard methods are imperative. This review summarizes the current progress in approaches assessing nanotoxicity in main systems, including the hepatic and renal, gastrointestinal, pulmonary, cardiovascular, nervous, and immune systems. Histopathological studies and specific functional examinations in each system are elucidated. Related injury mechanisms are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bermudez, E., Mangum, J. B., Wong, B. A., Asgharian, B., Hext, P. M., Warheit, D. B., & Everitt, J. I. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh019 · Cited by 652 · cited 1×
“The most common method is intratracheal instillation for long-term [70, 71] and shortterm [72] toxicity assessments, in which the bronchoalveolar lavage (BAL) fluid [73] is collected for biochemical analysis, including lactate dehydrogenase (LDH) assay.”
MethodIn vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems
Semete, B., Booysen, L., Lemmer, Y., Kalombo, L., Katata, L., Verschoor, J., & Swai, H. S. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2010.02.002 · Cited by 425 · cited 1×
“Some fluorescent-labeled particles [43] in tissue homogenates were analyzed by plate reader.”
MethodMicroscopic localization of PEG-liposomes in a rat model of focal infection
Laverman, P., Dams, E. T. M., Storm, G., Hafmans, T. G., Croes, H. J., Oyen, W. J. G., Corstens, F. H. M., & Boerman, O. C. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00402-3 · Cited by 53 · cited 1×
“Typical symptoms of phlebitis [77] can be seen through pathological sections.”
Background
Cited by
Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review
Hossen, S., Hossain, M. K., Basher, M. K., Mia, M. N. H., Rahman, M. T., & Uddin, M. J. (2019) · Journal of Advanced Research · doi:10.1016/j.jare.2018.06.005 · Cited by 998
“The research scope for toxicity studies is still wide open [293,294].”
BackgroundRecent advances on antimicrobial wound dressing: A review
Simões, D., Miguel, S. P., Ribeiro, M. P., Coutinho, P., Mendonça, A. G., & Correia, I. J. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.02.022 · Cited by 935
Treatment Strategies for Infected Wounds
Negut, I., Grumezescu, V., & Grumezescu, A. M. (2018) · Molecules · doi:10.3390/molecules23092392 · Cited by 739
Yang, W., Wang, L., Mettenbrink, E. M., DeAngelis, P. L., & Wilhelm, S. (2021) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-032320-110338 · Cited by 327
Domingues, C., Santos, A., Alvarez-Lorenzo, C., Concheiro, A., Jarak, I., Veiga, F., Barbosa, I., Dourado, M., & Figueiras, A. (2022) · ACS Nano · doi:10.1021/acsnano.2c00128 · Cited by 235
Metadata
- Authors
- Yang, Y., Qin, Z., Zeng, W., Yang, T., Cao, Y., Mei, C., & Kuang, Y.
- Venue
- Nanotechnology Reviews
- Publisher
- Walter de Gruyter GmbH
- Published
- 2017-06-27
- Volume
- 6
- Issue
- 3
- Pages
- 279-289
- ISSN
- 2191-9089 (ISSN-L)
- 2191-9097
- OpenAlex
- W2550501731
- Cited by
- 212
- References
- 3
- FWCI
- 5.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.